Mouse Anti-FBXO31 Recombinant Antibody (1C5) (CBMAB-A2886-LY)

Islam, S., Dutta, P., Sahay, O., Gopalakrishnan, K., Muhury, S. R., Parameshwar, P., ... & Santra, M. K. (2022). Feedback‐regulated transcriptional repression of FBXO31 by c‐Myc triggers ovarian cancer tumorigenesis. International Journal of Cancer, 150(9), 1512-1524.

Zhu, Z., Zheng, Y., He, H., Yang, L., Yang, J., Li, M., ... & Huang, H. (2022). FBXO31 sentisizes CSC‐like cells to cisplatin by promoting ferroptosis and facilitating proteasomal degradation of GPX4 in CCA. Liver International.

Lv, L., chao Wang, S., you Mo, J., lin Huang, K., li Xu, M., & Liu, J. (2022). Effects and mechanisms of FBXO31 on Taxol chemoresistance in esophageal squamous cell carcinoma. Biochemical and Biophysical Research Communications, 586, 129-136.

Liu, J., Zang, Y., Ma, C., Wang, D., Tian, Z., Xu, X., ... & Liu, Z. (2022). Pseudophosphatase STYX is induced by Helicobacter pylori and promotes gastric cancer progression by inhibiting FBXO31 function. Cell death & disease, 13(3), 1-12.

Feng, Y., Liu, M., Xie, P., Dong, R., & Hao, Z. (2022). FBXO31 suppresses lipogenesis and tumor progression in glioma by promoting ubiquitination and degradation of CD147. Prostaglandins & Other Lipid Mediators, 163, 106667.

Tsai, P. H., Chen, L. Z., Tseng, K. F., Chen, F. Y., & Shen, M. Y. (2022). Apolipoprotein C3-Rich Low-Density Lipoprotein Induces Endothelial Cell Senescence via FBXO31 and Its Inhibition by Sesamol In Vitro and In Vivo. Biomedicines, 10(4), 854.

Duan, S., Moro, L., Qu, R., Simoneschi, D., Cho, H., Jiang, S., ... & Pagano, M. (2021). Loss of FBXO31-mediated degradation of DUSP6 dysregulates ERK and PI3K-AKT signaling and promotes prostate tumorigenesis. Cell reports, 37(3), 109870.

Liu, K., Xue, B., Bai, G., & Zhang, W. (2020). F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis. Life sciences, 259, 118277.

He, H., Dai, J., Feng, J., He, Q., Chen, X., Dai, W., ... & Huang, H. (2020). FBXO31 modulates activation of hepatic stellate cells and liver fibrogenesis by promoting ubiquitination of Smad7. Journal of Cellular Biochemistry, 121(8-9), 3711-3719.

Li, B., Hong, P., Zheng, C. C., Dai, W., Chen, W. Y., Yang, Q. S., ... & Cheung, A. L. (2019). Identification of miR-29c and its target FBXO31 as a key regulatory mechanism in esophageal cancer chemoresistance: functional validation and clinical significance. Theranostics, 9(6), 1599.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols